Whole-Blood vs Component Therapy in Adult Trauma
JAMA Surgery · 01.05.2026 · 161 (5) · 497
DOI: 10.1001/jamasurg.2026.0197 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift JAMA Surgery, erschienen am 01.05.2026. Verfasst von Wesam Ibrahim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of GI, Trauma, and Endocrine Surgery, Department of Surgery, University of Colorado, Aurora. Hauptthemen laut MEDLINE: Wounds and Injuries, Blood Transfusion, Hemorrhage, Blood Component Transfusion. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Hemorrhage remains the leading preventable cause of trauma-related death. The effectiveness of whole-blood vs component therapy remains uncertain, particularly given heterogeneous patient populations and resuscitation protocols.
Objective
To determine whether whole-blood transfusion is associated with reduced mortality compared with component therapy in adult trauma patients, with prespecified analysis by civilian vs military settings. Evidence Review In this updated systematic review and meta-analysis, MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Web of Science, and CINAHL were searched from January 1, 2006, through June 30, 2025. Two reviewers independently screened 6888 records and extracted data. Randomized clinical trials and observational studies comparing whole-blood vs component therapy in adults (aged ≥16 years) with traumatic hemorrhage were included. The Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) tool was used to assess the risk of bias in observational studies, while the Cochrane Risk of Bias 2 (RoB 2) tool was applied for randomized clinical trials. Random-effects meta-analysis used restricted maximum likelihood with Hartung-Knapp adjustment.
Findings
Forty studies (2 randomized clinical trials, 38 cohort studies; n = 49 776) were included. Whole-blood transfusion, compared with component therapy, was associated with reduced 24-hour mortality (odds ratio [OR], 0.76; 95% CI, 0.60-0.95; τ 2 = 0.27; I 2 = 87%; 95% prediction interval [PI], 0.30-1.89). In civilians (24 studies; n = 39 028), mortality reduction was significant (OR, 0.73; 95% CI, 0.57-0.93; τ 2 = 0.27; I 2 = 89%; 95% PI, 0.28-1.91), corresponding to an absolute risk reduction of 4.6 percentage points (95% CI, 1.4-8.6 percentage points) based on median control mortality of 20% (range, 15%-25%). No benefit was observed in military settings (5 studies; n = 2171; OR, 0.99; 95% CI, 0.58-1.70). Civilians also showed reduced 30-day mortality (OR, 0.76; 95% CI, 0.60-0.98) and transfusion requirements (mean difference, −2.66 units; 95% CI, −3.96 to −1.35 units). Conclusions and Relevance In this updated systematic review and meta-analysis, whole-blood transfusion was associated with reduced mortality in civilian but not military adult trauma patients, although the wide 95% PIs suggest substantial heterogeneity, indicating that benefits may vary considerably across settings. These findings support selective whole-blood transfusion protocol implementation in civilian centers while highlighting the need for refined patient selection criteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of GI, Trauma, and Endocrine Surgery, Department of Surgery, University of Colorado, Aurora.
- Trauma and Emergency Department, Tanta University, Tanta, Egypt.
- Department of Surgery, Universidad de Carabobo, School of Medicine, Valencia, Venezuela.
- Department of Surgery, Universidad de los Andes, Mérida, Venezuela.
- Epidemiology Department, Sociedad de Cirugía de Bogotá Hospital de San José, Bogotá, Colombia.
- Dr Juan Ignacio Gutierrez Sacasa School of Medicine, Universidad de Defensa de Nicaragua, León, Nicaragua.
Zitieren
APA
Ibrahim, W., Meza Monge, K., Menzel, J., Morales Ojeda, L., Dalton, M., Fuenmayor Lozada, D. A., Vidal-Gallardo, A., Fonseca Niño, A. M., Aragón Conrado, L. E., Cripps, M. W., & Idrovo, J. P. (2026). Whole-Blood vs Component Therapy in Adult Trauma. JAMA Surgery, 161(5), 497. https://doi.org/10.1001/jamasurg.2026.0197
Vancouver
Ibrahim W, Meza Monge K, Menzel J, Morales Ojeda L, Dalton M, Fuenmayor Lozada DA, et al. Whole-Blood vs Component Therapy in Adult Trauma. JAMA Surgery. 2026;161(5):497. doi:10.1001/jamasurg.2026.0197
BibTeX
@article{Ibrahim2026,
author = {Ibrahim, Wesam and Meza Monge, Kenneth and Menzel, Johannes and Morales Ojeda, Luis and Dalton, Michael and Fuenmayor Lozada, Daniel Alejandro and Vidal-Gallardo, Andrea and Fonseca Niño, Angelica Maria and Aragón Conrado, Lorenzo E and Cripps, Michael W and Idrovo, Juan-Pablo},
title = {Whole-Blood vs Component Therapy in Adult Trauma},
journal = {JAMA Surgery},
year = {2026},
volume = {161},
number = {5},
pages = {497},
doi = {10.1001/jamasurg.2026.0197}
}
EUVIMED